<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Stock Blog Hub &#187; Hi Tech Pharmacal Company Inc</title>
	<atom:link href="http://www.stockbloghub.com/tag/hi-tech-pharmacal-company-inc/feed" rel="self" type="application/rss+xml" />
	<link>http://www.stockbloghub.com</link>
	<description>Start Your Investing Research Here!</description>
	<lastBuildDate>Wed, 23 May 2012 20:22:08 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.2</generator>
		<item>
		<title>(HITK) Hi-Tech Pharmacal &#8211; Reports Another Earnings Surprise</title>
		<link>http://www.stockbloghub.com/2010/04/12/hitk-hi-tech-pharmacal-reports-another-earnings-surprise/33401</link>
		<comments>http://www.stockbloghub.com/2010/04/12/hitk-hi-tech-pharmacal-reports-another-earnings-surprise/33401#comments</comments>
		<pubDate>Mon, 12 Apr 2010 17:26:30 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Drugs - Generic]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Hi Tech Pharmacal Company Inc]]></category>
		<category><![CDATA[HITK]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=33401</guid>
		<description><![CDATA[Hi-Tech Pharmacal Co. (HITK) continues to trade at great valuations and have plenty of earnings momentum. Company Description Hi-Tech Pharmacal makes generic and branded pharmaceuticals, both over-the-counter and prescription. The company focuses on liquid and semi-solid forms for ophthalmic, otic, and inhalable products. Another Surprise Hi-Tech Pharmacal reported quarterly results on Mar 11 that yielded EPS of 67 cents, 17 cents ahead of the Zacks Consensus Estimate. This was the company&#8217;s fourth consecutive earnings surprise. Sales jumped 32% to $38.8 million during the period. Estimates Pop Following the earnings release full-year estimates for fiscal 2010 jumped to $2.44, up from $2.06 over the past 3 months. The revisions have kept shares of HITK cheap. The stock is trading at just 9 times forward earnings. Estimates for next year are expected ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/04/12/hitk-hi-tech-pharmacal-reports-another-earnings-surprise/33401/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(HITK) Hi-Tech Pharmacal Co. &#8211; Earnings Estimates Jump Big!</title>
		<link>http://www.stockbloghub.com/2009/12/29/hitk-hi-tech-pharmacal-co-earnings-estimates-jump-big/23802</link>
		<comments>http://www.stockbloghub.com/2009/12/29/hitk-hi-tech-pharmacal-co-earnings-estimates-jump-big/23802#comments</comments>
		<pubDate>Tue, 29 Dec 2009 19:17:33 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Drugs - Generic]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Hi Tech Pharmacal Company Inc]]></category>
		<category><![CDATA[HITK]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=23802</guid>
		<description><![CDATA[Hi-Tech Pharmacal Co (HITK) estimates are surging following the latest earnings report, which showed earnings rise more than 600%. Company Description Hi-Tech makes generic and branded pharmaceuticals, both over-the-counter and prescription. The company focuses on liquid and semi-solid forms for ophthalmic, otic, and inhalable products. Quarterly Results On Dec 9 Hi-Tech reported second-quarter results that showed sales increased by 64%, to just under $41 million. This led to a surge in net income, which was up almost 7 fold, to $7.4 million. Earnings per share came in at 60 cents, 28 cents higher than the Zacks Consensus Estimate. This was the third consecutive earnings surprise. Estimates Jump Full-year estimates for fiscal 2010 are now averaging $2.06, up from $1.42 over the past 30 days. This is compared to 78 cents ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2009/12/29/hitk-hi-tech-pharmacal-co-earnings-estimates-jump-big/23802/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(PRX) Top Performer for Thurs: Par Pharmaceutical Companies</title>
		<link>http://www.stockbloghub.com/2009/10/15/prx-top-performer-for-thurs-par-pharmaceutical-companies/17743</link>
		<comments>http://www.stockbloghub.com/2009/10/15/prx-top-performer-for-thurs-par-pharmaceutical-companies/17743#comments</comments>
		<pubDate>Thu, 15 Oct 2009 22:29:17 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Drugs - Generic]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Dr. Reddy's Laboratories Limited]]></category>
		<category><![CDATA[Hi Tech Pharmacal Company Inc]]></category>
		<category><![CDATA[HITK]]></category>
		<category><![CDATA[Impax Laboratories Inc]]></category>
		<category><![CDATA[IPXL]]></category>
		<category><![CDATA[Par Pharmaceutical Companies Inc]]></category>
		<category><![CDATA[PRX]]></category>
		<category><![CDATA[RDY]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=17743</guid>
		<description><![CDATA[Par Pharmaceutical Companies, Inc. (PRX) received a brokerage firm upgrade today, which is helping it to gain during a rather muted morning session. In addition, PRX has been enjoying rising earnings estimates that have pushed the 2009 and 2010 Zacks Consensus Estimates higher in just the past 7 days. The company made the Zacks #1 Rank Top Performers List for Thursday with shares that are up approximately 4.4%. Volume is at 716,000 shares; above the daily average of 301,000. Par Pharmaceutical develops, manufactures and markets generic drugs and innovative branded pharmaceuticals for specialty markets. It is part of the Medical-Generic Drugs industry. There are 3 other names from this space on today&#8217;s Zacks #1 Rank List: Dr. Reddy&#8217;s Laboratories Ltd. (RDY), Hi-Tech Pharmacal Company, Inc. (HITK) and Impax Laboratories, Inc. ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2009/10/15/prx-top-performer-for-thurs-par-pharmaceutical-companies/17743/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(HITK) Top Performer for Wed: Hi-Tech Pharmacal- Zacks #1 Rank Top Performers</title>
		<link>http://www.stockbloghub.com/2009/10/03/hitk-top-performer-for-wed-hi-tech-pharmacal-zacks-1-rank-top-performers/16354</link>
		<comments>http://www.stockbloghub.com/2009/10/03/hitk-top-performer-for-wed-hi-tech-pharmacal-zacks-1-rank-top-performers/16354#comments</comments>
		<pubDate>Sat, 03 Oct 2009 22:53:13 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Drugs - Generic]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Hi Tech Pharmacal Company Inc]]></category>
		<category><![CDATA[HITK]]></category>
		<category><![CDATA[Impax Laboratories Inc]]></category>
		<category><![CDATA[IPXL]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com.php5-2.dfw1-2.websitetestlink.com/?p=16354</guid>
		<description><![CDATA[Hi-Tech Pharmacal Co., Inc. (HITK) enjoyed a strong performance from generic pharmaceuticals in its fiscal first quarter, leading to a sharp earnings surprise and large revenue growth. With a gain of only around 3.8%, HITK is a top-performing Zacks #1 Rank company today. Volume is at 514,000, versus the daily average of 586,000. HITK is a specialty pharmaceutical company developing, manufacturing and marketing generic and branded prescription and OTC products. It specializes in difficult-to-manufacture liquid and semi-solid dosage forms and produces a range of sterile ophthalmic, otic and inhalation products. The company is part of the Medical-Generic Drugs industry. There is only 1 other name from that space on today&#8217;s 218-stock Zacks #1 Rank List, and that is Impax Laboratories, Inc. (IPXL). Strong Fiscal First Quarter In early September, HITK ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2009/10/03/hitk-top-performer-for-wed-hi-tech-pharmacal-zacks-1-rank-top-performers/16354/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

